Priti Hegde, PhD, Chief Scientific Officer
Dr. Hegde joined Foundation Medicine as the Chief Scientific Officer in August 2019. Her team comprises of Cancer Genomics, Research and Early Development, Computational Biology, Translational Strategy, Franchise Development, and Product Development (inclusive of Assay Development, Companion Diagnostic Development Operations, Regulatory, and Biomarkers and Biometrics.)
Dr. Hegde has spent nearly two decades in the biopharmaceutical industry, developing integrated research strategies in precision medicine, with a proven track record in research, drug development, registration, and commercialization of therapeutics.
Current Open Roles on the Team:
| Scientific Copy Editor | Translational Oncology and Clinical Reporting | 100247 | San Diego | California | United States | San Diego, California, United States | Translational Oncology and Clinical Reporting | About the Job The Scientific Copy Editor is integrated within a team of scientists to carry out scientific editing tasks, organizational tasks, operational tasks, and literature research in support of Foundation Medicine’s medical reporting proce... | ||
| Senior Scientist | Development Operations | 100229 | Cambridge | Massachusetts | United States | Cambridge, Massachusetts, United States | Development Operations | Key Responsibilities • Lead, author, and execute development, verification, and validation studies for novel diagnostic next generation sequencing assays. • Lead training on new processes as they pertain to applicable cross-functional participan... | ||
| Associate Director, Development Operations | Development Operations | 100230 | Cambridge | Massachusetts | United States | Cambridge, Massachusetts, United States | Development Operations | Key Responsibilities • Manage, author and lead development, verification, and validation studies for novel diagnostic next generation sequencing assays. • Manage a team comprised of scientists and research associates and conduct hiring, performa... | ||
| Systems Analyst | Computational Biology | 100226 | Boston | Massachusetts | United States | Boston, Massachusetts, United States | Computational Biology | Key Responsibilities • Maintain requirement and design specifications as well as other documentation required for software development and change control processes. • Work independently as well as collaborate in a larger team setting. • Author ... | ||
| Senior Scientist | Development Operations | 100227 | Cambridge | Massachusetts | United States | Cambridge, Massachusetts, United States | Development Operations | Key Responsibilities: • Lead, author, and execute development, verification, and validation studies for novel diagnostic next generation sequencing assays. • Lead training on new processes as they pertain to applicable cross-functional participant... | ||
| Scientist I | Development Operations | 100228 | Cambridge | Massachusetts | United States | Cambridge, Massachusetts, United States | Development Operations | Key Responsibilities • Prepare and handle biological specimens including blood, plasma, formalin-fixed paraffin-embedded samples, and extracted nucleic acids. • Execute development, verification, and validation studies for novel diagnostic NGS a... | ||
| Software Engineer III | Computational Biology | 100200 | Boston | Massachusetts | United States | Boston, Massachusetts, United States | Computational Biology | Key Responsibilities Help define and participate in software development processes that leverages best practice and supports continuous product delivery. Create custom programs and applications as designated by business need. Write, test, ... | ||
| Sr Research Associate | Assay Development | 100176 | Cambridge | Massachusetts | United States | Cambridge, Massachusetts, United States | Assay Development | About the Job The Senior Research Associate (SRA), Product Development leads and manages the participation in internal research projects and development of Next Generation Sequencing (NGS)-based molecular diagnostic assays for this purpose. As a ... | ||
| Sr Dir, Early Research & Development | Research and Early Development | 100108 | San Diego | California | United States | San Diego, California, United States | Research and Early Development | About the Job The Senior Director leads the Early Research and Development department and leads systematic reviews of new technologies and biomarker candidates as well as assigned projects to addressing unmet needs in the oncology field. The pos... | ||
| Computational Biologist | Computational Biology | 100004 | United States | United States | Computational Biology | About the Job The Computational Biologist on the Computational Biology Team provides computational, bioinformatic and statistical activities to enrich the analytical capabilities of existing products as medical knowledge advances, as well as to d... | ||||
| Manager, Franchise Development | Franchise Development | TBEREQ-20097 | Cambridge | Massachusetts | United States | Cambridge, Massachusetts, United States | Franchise Development | About the Job The Manager, Franchise Development provides technical oversight of companion diagnostic (CDx) development projects in collaboration with an external biopharma partner. The position works cross-functionally to ensure FMI meets the re... | ||
| Regulatory Affairs Manager | Regulatory | TBEREQ-20027 | Cambridge | Massachusetts | United States | Cambridge, Massachusetts, United States | Regulatory | About the Job The Manager, Regulatory Affairs is responsible for supporting the regulatory function and its activities, the development of regulatory strategy, and contributing the regulatory approval process (including US FDA and other regulator... | ||
| Director, Regulatory Affairs | Regulatory | TBEREQ-10539 | Cambridge | Massachusetts | United States | Cambridge, Massachusetts, United States | Regulatory | ABOUT THE JOB The Director, Regulatory Affairs is responsible for leading the international regulatory function and its activities, the development of international regulatory strategy, and for approval and registration of products in countries o... |
The Power Of Partnership In Precision Medicine
FoundationOne CDx was recently approved to identify mutations that lead to MET exon 14 skipping in advanced non-small cell lung cancer (NSCLC) and match patients with a new targeted therapy, which was approved in parallel.
Learn more on our blog about how this approval demonstrates the power of cancer precision medicine in action and the role that comprehensive genomic profiling plays.
- Garrett Frampton, PhD, Sr. Director, Cancer Genomics
The Best of the AACR Journals Collection
The Best of the AACR Journals collection highlights the most-cited articles published in 2018 across the AACR journals. Congratulations to our Director of Cancer Genomics Research, Lee A. Albacker for his most-cited article entitled STK11/LKB1 Mutations and PD-1 Inhibitor Resistance in KRAS-Mutant Lung Adenocarcinoma.
Learn a bit more about us:
